Logo image of CCL

CARNIVAL CORP (CCL) Stock Fundamental Analysis

NYSE:CCL - New York Stock Exchange, Inc. - PA1436583006 - Common Stock - Currency: USD

17.24  -0.75 (-4.17%)

After market: 17.2104 -0.03 (-0.17%)

Fundamental Rating

4

CCL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 136 industry peers in the Hotels, Restaurants & Leisure industry. CCL has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCL may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CCL had positive earnings in the past year.
CCL had a positive operating cash flow in the past year.
In the past 5 years CCL reported 4 times negative net income.
In multiple years CCL reported negative operating cash flow during the last 5 years.
CCL Yearly Net Income VS EBIT VS OCF VS FCFCCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

CCL has a Return On Assets of 4.23%. This is in the better half of the industry: CCL outperforms 64.71% of its industry peers.
Looking at the Return On Equity, with a value of 22.35%, CCL belongs to the top of the industry, outperforming 80.15% of the companies in the same industry.
The Return On Invested Capital of CCL (8.21%) is better than 65.44% of its industry peers.
Industry RankSector Rank
ROA 4.23%
ROE 22.35%
ROIC 8.21%
ROA(3y)-2.68%
ROA(5y)-8.99%
ROE(3y)-22.2%
ROE(5y)-38.93%
ROIC(3y)N/A
ROIC(5y)N/A
CCL Yearly ROA, ROE, ROICCCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

CCL has a better Profit Margin (8.07%) than 66.91% of its industry peers.
CCL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 15.11%, CCL is in the better half of the industry, outperforming 66.18% of the companies in the same industry.
CCL's Operating Margin has declined in the last couple of years.
CCL's Gross Margin of 53.19% is fine compared to the rest of the industry. CCL outperforms 63.97% of its industry peers.
In the last couple of years the Gross Margin of CCL has grown nicely.
Industry RankSector Rank
OM 15.11%
PM (TTM) 8.07%
GM 53.19%
OM growth 3YN/A
OM growth 5Y-1.91%
PM growth 3YN/A
PM growth 5Y-11.81%
GM growth 3YN/A
GM growth 5Y6.74%
CCL Yearly Profit, Operating, Gross MarginsCCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCL is still creating some value.
The number of shares outstanding for CCL has been increased compared to 1 year ago.
Compared to 5 years ago, CCL has more shares outstanding
The debt/assets ratio for CCL has been reduced compared to a year ago.
CCL Yearly Shares OutstandingCCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CCL Yearly Total Debt VS Total AssetsCCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

Based on the Altman-Z score of 0.99, we must say that CCL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.99, CCL is doing worse than 66.18% of the companies in the same industry.
CCL has a debt to FCF ratio of 13.60. This is a negative value and a sign of low solvency as CCL would need 13.60 years to pay back of all of its debts.
The Debt to FCF ratio of CCL (13.60) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.78 is on the high side and indicates that CCL has dependencies on debt financing.
CCL has a Debt to Equity ratio (2.78) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF 13.6
Altman-Z 0.99
ROIC/WACC1
WACC8.21%
CCL Yearly LT Debt VS Equity VS FCFCCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 0.26 indicates that CCL may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.26, CCL is doing worse than 92.65% of the companies in the same industry.
CCL has a Quick Ratio of 0.26. This is a bad value and indicates that CCL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.21, CCL is not doing good in the industry: 93.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.21
CCL Yearly Current Assets VS Current LiabilitesCCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

CCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 385.29%, which is quite impressive.
The earnings per share for CCL have been decreasing by -20.70% on average. This is quite bad
The Revenue has grown by 12.66% in the past year. This is quite good.
Measured over the past years, CCL shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)385.29%
EPS 3YN/A
EPS 5Y-20.7%
EPS Q2Q%192.86%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y135.82%
Revenue growth 5Y3.74%
Sales Q2Q%7.47%

3.2 Future

The Earnings Per Share is expected to grow by 18.55% on average over the next years. This is quite good.
CCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.12% yearly.
EPS Next Y36.11%
EPS Next 2Y25.04%
EPS Next 3Y22.09%
EPS Next 5Y18.55%
Revenue Next Year4.54%
Revenue Next 2Y4.16%
Revenue Next 3Y3.9%
Revenue Next 5Y4.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CCL Yearly Revenue VS EstimatesCCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
CCL Yearly EPS VS EstimatesCCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

CCL is valuated reasonably with a Price/Earnings ratio of 10.45.
CCL's Price/Earnings ratio is rather cheap when compared to the industry. CCL is cheaper than 87.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of CCL to the average of the S&P500 Index (28.29), we can say CCL is valued rather cheaply.
A Price/Forward Earnings ratio of 7.99 indicates a rather cheap valuation of CCL.
CCL's Price/Forward Earnings ratio is rather cheap when compared to the industry. CCL is cheaper than 90.44% of the companies in the same industry.
CCL is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.45
Fwd PE 7.99
CCL Price Earnings VS Forward Price EarningsCCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CCL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CCL is cheaper than 76.47% of the companies in the same industry.
CCL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCL is cheaper than 84.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.39
EV/EBITDA 7.73
CCL Per share dataCCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCL's earnings are expected to grow with 22.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y25.04%
EPS Next 3Y22.09%

0

5. Dividend

5.1 Amount

CCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CARNIVAL CORP

NYSE:CCL (4/21/2025, 5:10:50 PM)

After market: 17.2104 -0.03 (-0.17%)

17.24

-0.75 (-4.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-21 2025-03-21/bmo
Earnings (Next)06-23 2025-06-23/amc
Inst Owners62.46%
Inst Owner Change-0.1%
Ins Owners7.57%
Ins Owner Change0.42%
Market Cap22.62B
Analysts80.63
Price Target29.23 (69.55%)
Short Float %5.59%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)307.47%
Min EPS beat(2)83.06%
Max EPS beat(2)531.88%
EPS beat(4)4
Avg EPS beat(4)345.5%
Min EPS beat(4)8.2%
Max EPS beat(4)758.87%
EPS beat(8)8
Avg EPS beat(8)184.17%
EPS beat(12)10
Avg EPS beat(12)96.34%
EPS beat(16)10
Avg EPS beat(16)67.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.88%
Max Revenue beat(2)0.05%
Revenue beat(4)2
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-0.88%
Max Revenue beat(4)0.75%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)6
Avg Revenue beat(12)-2.18%
Revenue beat(16)6
Avg Revenue beat(16)-10.24%
PT rev (1m)-1.97%
PT rev (3m)4.09%
EPS NQ rev (1m)3.38%
EPS NQ rev (3m)9.8%
EPS NY rev (1m)5.63%
EPS NY rev (3m)6.81%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 10.45
Fwd PE 7.99
P/S 0.89
P/FCF 11.39
P/OCF 4.45
P/B 2.46
P/tB 3.04
EV/EBITDA 7.73
EPS(TTM)1.65
EY9.57%
EPS(NY)2.16
Fwd EY12.51%
FCF(TTM)1.51
FCFY8.78%
OCF(TTM)3.87
OCFY22.46%
SpS19.38
BVpS7
TBVpS5.67
PEG (NY)0.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.23%
ROE 22.35%
ROCE 10.4%
ROIC 8.21%
ROICexc 8.4%
ROICexgc 8.83%
OM 15.11%
PM (TTM) 8.07%
GM 53.19%
FCFM 7.81%
ROA(3y)-2.68%
ROA(5y)-8.99%
ROE(3y)-22.2%
ROE(5y)-38.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.03%
ROICexc growth 3YN/A
ROICexc growth 5Y1.43%
OM growth 3YN/A
OM growth 5Y-1.91%
PM growth 3YN/A
PM growth 5Y-11.81%
GM growth 3YN/A
GM growth 5Y6.74%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF 13.6
Debt/EBITDA 3.96
Cap/Depr 119.13%
Cap/Sales 12.17%
Interest Coverage 250
Cash Conversion 78.9%
Profit Quality 96.78%
Current Ratio 0.26
Quick Ratio 0.21
Altman-Z 0.99
F-Score7
WACC8.21%
ROIC/WACC1
Cap/Depr(3y)178.87%
Cap/Depr(5y)171.94%
Cap/Sales(3y)24.77%
Cap/Sales(5y)65.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)385.29%
EPS 3YN/A
EPS 5Y-20.7%
EPS Q2Q%192.86%
EPS Next Y36.11%
EPS Next 2Y25.04%
EPS Next 3Y22.09%
EPS Next 5Y18.55%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y135.82%
Revenue growth 5Y3.74%
Sales Q2Q%7.47%
Revenue Next Year4.54%
Revenue Next 2Y4.16%
Revenue Next 3Y3.9%
Revenue Next 5Y4.12%
EBIT growth 1Y59.82%
EBIT growth 3YN/A
EBIT growth 5Y1.76%
EBIT Next Year90.99%
EBIT Next 3Y28.88%
EBIT Next 5Y18.36%
FCF growth 1Y159.2%
FCF growth 3YN/A
FCF growth 5Y94.16%
OCF growth 1Y7358.57%
OCF growth 3YN/A
OCF growth 5Y1.58%